Infliximab treatment efficacy in lymphoedema associated with ankylosing spondylitis.
Almodóvar
R
R
Zarco
P
P
Quirós
F J
FJ
Mazzucchelli
R
R
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D008209:Lymphedema / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013167:Spondylitis, Ankylosing / Q000150:complications*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab